Accendra Health Statistics
Total Valuation
Accendra Health has a market cap or net worth of $214.43 million. The enterprise value is $2.05 billion.
Important Dates
The last earnings date was Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Accendra Health has 76.58 million shares outstanding. The number of shares has decreased by -0.38% in one year.
| Current Share Class | 76.58M |
| Shares Outstanding | 76.58M |
| Shares Change (YoY) | -0.38% |
| Shares Change (QoQ) | -0.35% |
| Owned by Insiders (%) | 9.46% |
| Owned by Institutions (%) | 67.62% |
| Float | 56.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.62 |
| PS Ratio | 0.08 |
| Forward PS | 0.08 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.75 |
| EV / EBITDA | 6.33 |
| EV / EBIT | 22.67 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.49
| Current Ratio | 0.49 |
| Quick Ratio | 0.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.35 |
| Debt / FCF | n/a |
| Interest Coverage | 0.74 |
Financial Efficiency
Return on equity (ROE) is -198.35% and return on invested capital (ROIC) is 6.48%.
| Return on Equity (ROE) | -198.35% |
| Return on Assets (ROA) | 1.55% |
| Return on Invested Capital (ROIC) | 6.48% |
| Return on Capital Employed (ROCE) | 7.45% |
| Weighted Average Cost of Capital (WACC) | 5.27% |
| Revenue Per Employee | $417,835 |
| Profits Per Employee | -$166,481 |
| Employee Count | 6,500 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 1.99 |
Taxes
| Income Tax | -7.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.28% in the last 52 weeks. The beta is 1.70, so Accendra Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.70 |
| 52-Week Price Change | -56.28% |
| 50-Day Moving Average | 2.93 |
| 200-Day Moving Average | 3.43 |
| Relative Strength Index (RSI) | 42.14 |
| Average Volume (20 Days) | 943,476 |
Short Selling Information
The latest short interest is 5.95 million, so 7.77% of the outstanding shares have been sold short.
| Short Interest | 5.95M |
| Short Previous Month | 7.54M |
| Short % of Shares Out | 7.77% |
| Short % of Float | 10.59% |
| Short Ratio (days to cover) | 8.06 |
Income Statement
In the last 12 months, Accendra Health had revenue of $2.72 billion and -$1.08 billion in losses. Loss per share was -$14.11.
| Revenue | 2.72B |
| Gross Profit | 1.25B |
| Operating Income | 90.37M |
| Pretax Income | -112.80M |
| Net Income | -1.08B |
| EBITDA | 323.73M |
| EBIT | 90.37M |
| Loss Per Share | -$14.11 |
Full Income StatementBalance Sheet
The company has $338.49 million in cash and $2.17 billion in debt, with a net cash position of -$1.83 billion or -$23.92 per share.
| Cash & Cash Equivalents | 338.49M |
| Total Debt | 2.17B |
| Net Cash | -1.83B |
| Net Cash Per Share | -$23.92 |
| Equity (Book Value) | -464.77M |
| Book Value Per Share | -6.07 |
| Working Capital | -614.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$116.80 million and capital expenditures -$186.81 million, giving a free cash flow of -$303.61 million.
| Operating Cash Flow | -116.80M |
| Capital Expenditures | -186.81M |
| Depreciation & Amortization | 233.36M |
| Net Borrowing | 157.50M |
| Free Cash Flow | -303.61M |
| FCF Per Share | -$3.96 |
Full Cash Flow StatementMargins
Gross margin is 45.95%, with operating and profit margins of 3.33% and -39.84%.
| Gross Margin | 45.95% |
| Operating Margin | 3.33% |
| Pretax Margin | -4.15% |
| Profit Margin | -39.84% |
| EBITDA Margin | 11.92% |
| EBIT Margin | 3.33% |
| FCF Margin | n/a |
Dividends & Yields
Accendra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.38% |
| Shareholder Yield | 0.38% |
| Earnings Yield | -499.29% |
| FCF Yield | -140.09% |
Analyst Forecast
The average price target for Accendra Health is $4.49, which is 60.36% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.49 |
| Price Target Difference | 60.36% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 1, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Apr 1, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Accendra Health has an Altman Z-Score of 0.39 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.39 |
| Piotroski F-Score | 4 |
